close

Natus Medical Incorporated develops, manufactures, and markets neurondiagnostic and newborn care products worldwide. It provides healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company's product offerings include neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems and phototherapy devices for the treatment of jaundice in newborn; head-cooling products for the treatment of brain injury and jaundice in newborns; and software systems for managing and tracking disorders and diseases for public health laboratories. The newborn hearing screening products consist of the ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners, which are used with newborn hearing screening devices; and diagnostic hearing assessment products, including the Navigator Pro system, the Scout Sport portable diagnostic device, the HINT PRO, the AuDX PRO, the Cochlea-Scan, and the Centor that are used to identify abnormalities affecting the peripheral and central auditory nervous systems; and diagnostic hearing supply products. Natus Medical also offers monitoring systems, balance and mobility products, and jaundice management products. In addition, the company offers medical devices, including photometers, radiometers, patient warming lamps, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, and newborn circumstraints; disposable supplies, which include neonatal noise attenuators, phototherapy eye masks, restraining boards, and x-ray shields; and newborn screening data management products. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. The company was founded in 1987 and is headquartered in San Carlos, California.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	11.11
Volume	306488
Volume Avg	201528
52 Week High	17.50
52 Week Low	7.43
PE	N/A
PE (group average)	39
EPS Year	-0.41
EPS change Q/Q	-42.11%
EPS change Q/Q Yr ago	-1000%
EPS change Q/Q next Q est	-26.67%
EPS change Y/Y	-35.19%
REV change Q/Q	-6.93%
REV change Q/Q Yr ago	19.88%
EPS next Q est	0.15
EPS next Y est	0.65
Divident Annual	0.00
Dividend Yield	0%